CHU Henri Mondor Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Paris France (1969)

Organization Overview

First Clinical Trial
2002
NCT00049595
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AP-HP Henri Mondor Créteil | Centre Hospitalier Universitaire Henri Mondor | Centre Hospitalo-Universitaire Henri Mondor, Service d'Hematologie Clinique | CH Henri Mondor (Aurillac) | CHU d'HENRI MONDOR | CHU Henri-Mondor | CHU Henri Mondor, Créteil | CHU Henri Mondor de Creteil | Department of internal medicine, Henri-Mondor Hospital, Creteil, France. | Groupe Hospitalier Albert Chenevier Henri Mondor | Head of the department of rheumatology Hopital Henri Mondor, Creteil, France | Henri Mondor Hospital | Henri Mondor Hospital, Créteil, France | Henri Mondor University Hospital | Hopital Henri Mondor | Hôpital Henri Mondor | Hôpital Henri Mondor, APHP CRETEIL | HOPITAL HENRI MONDOR - CRETEIL | Hopital Henri Mondor-France | Hôpitaux Universitaires Henri Mondor | HOSPITAL, HENRI MONDOR | Sebastien GALLIEN/Henri Mondor University Hospital- Infectiology Department | Service de médecine interne, Henri Mondor Hospital, APHP | THOMAS STEHL/ HENRI MONDOR HOSPITAL-Department of Nephrology | University Hospital, Henri Mondor/Albert Chenevier, Créteil